Research Design Service: East Midlands
« back

NIHR Nottingham Biomedical Research Centre signs collaboration agreement with AstraZeneca

  Created on Thursday, 03 May 2018.

The NIHR Nottingham Biomedical Research Centre has become the first in the UK to sign an agreement that could lead to the faster development of new treatments for some of the most common diseases, including arthritis and asthma.

Through the agreement, the BRC will have access to AstraZeneca's Open Innovation platform - an extensive range of AstraZeneca’s chemical compounds - as part of its work on the development of new therapies and treatments.

Read more about this story on the University of Nottingham website.